| John C Berg, MD | |
|
2024 S 6th St., Brainerd, MN 56401-3054 | |
| (218) 828-7100 | |
| Not Available |
| Full Name | John C Berg |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 42 Years |
| Location | 2024 S 6th St., Brainerd, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285612325 | NPI | - | NPPES |
| 946800500 | Medicaid | MN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 30400 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Essentia Health St Joseph's Medical Center | Brainerd, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Josephs Medical Center | 8224948443 | 215 |
News Archive
The Institute of Medicine today presented the 2013 Gustav O. Lienhard Award to Steven A. Schroeder, whose pioneering efforts to control tobacco use have helped save millions from premature, smoking-related deaths. The award also recognizes Schroeder's leadership in general medicine as well as his work to improve end-of-life care.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
In its commitment to provide diagnostic insights that enhance patient care and outcomes, Quest Diagnostics will automatically perform molecular testing on all patient specimens whose antibody screening results indicate hepatitis C virus infection, and remove standalone positive antibody screening as a test option.
Idera Pharmaceuticals, Inc. today announced the presentation of data from its multiple-dose Phase 1 clinical trial of IMO-3100 in healthy subjects.
› Verified 3 days ago
| Entity Name | St Josephs Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568415974 PECOS PAC ID: 8224948443 Enrollment ID: O20031119000468 |
News Archive
The Institute of Medicine today presented the 2013 Gustav O. Lienhard Award to Steven A. Schroeder, whose pioneering efforts to control tobacco use have helped save millions from premature, smoking-related deaths. The award also recognizes Schroeder's leadership in general medicine as well as his work to improve end-of-life care.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
In its commitment to provide diagnostic insights that enhance patient care and outcomes, Quest Diagnostics will automatically perform molecular testing on all patient specimens whose antibody screening results indicate hepatitis C virus infection, and remove standalone positive antibody screening as a test option.
Idera Pharmaceuticals, Inc. today announced the presentation of data from its multiple-dose Phase 1 clinical trial of IMO-3100 in healthy subjects.
› Verified 3 days ago
| Entity Name | Brainerd Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295801777 PECOS PAC ID: 0648270272 Enrollment ID: O20070105000140 |
News Archive
The Institute of Medicine today presented the 2013 Gustav O. Lienhard Award to Steven A. Schroeder, whose pioneering efforts to control tobacco use have helped save millions from premature, smoking-related deaths. The award also recognizes Schroeder's leadership in general medicine as well as his work to improve end-of-life care.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
In its commitment to provide diagnostic insights that enhance patient care and outcomes, Quest Diagnostics will automatically perform molecular testing on all patient specimens whose antibody screening results indicate hepatitis C virus infection, and remove standalone positive antibody screening as a test option.
Idera Pharmaceuticals, Inc. today announced the presentation of data from its multiple-dose Phase 1 clinical trial of IMO-3100 in healthy subjects.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John C Berg, MD 523 N 3rd St, Brainerd, MN 56401-3054 Ph: (218) 829-2861 | John C Berg, MD 2024 S 6th St., Brainerd, MN 56401-3054 Ph: (218) 828-7100 |
News Archive
The Institute of Medicine today presented the 2013 Gustav O. Lienhard Award to Steven A. Schroeder, whose pioneering efforts to control tobacco use have helped save millions from premature, smoking-related deaths. The award also recognizes Schroeder's leadership in general medicine as well as his work to improve end-of-life care.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.
A clinical trial evaluates - in humans - a drug, device or mode of therapy for a disease. All therapies put into use in the U.S. go through a rigorous process of testing, culminating in evaluation of the treatment in human research participants. In order to test new treatments, clinical trial investigators at research institutions like UK must recruit participants willing to contribute to science, while often reaping the benefits of advanced treatment for themselves, and gaining access to top clinicians and the latest medical information.
In its commitment to provide diagnostic insights that enhance patient care and outcomes, Quest Diagnostics will automatically perform molecular testing on all patient specimens whose antibody screening results indicate hepatitis C virus infection, and remove standalone positive antibody screening as a test option.
Idera Pharmaceuticals, Inc. today announced the presentation of data from its multiple-dose Phase 1 clinical trial of IMO-3100 in healthy subjects.
› Verified 3 days ago
Christa A Eickhoff, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2024 S 6th St, Brainerd, MN 56401 Phone: 218-828-7101 Fax: 218-828-2892 | |
Paul Milloy, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2024 S 6th St, Brainerd, MN 56401 Phone: 218-825-7100 | |
Hong Li, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2024 S 6th St, Brainerd, MN 56401 Phone: 218-828-7100 | |
Dr. Tyler John Dunphy, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2024 S 6th St, Brainerd, MN 56401 Phone: 218-828-7100 | |
Ronald Halvorson, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 9919 Cove Pointe Rd, Brainerd, MN 56401 Phone: 218-828-7100 | |
Mrs. Linda Tigenoah, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 523 N 3rd St, Brainerd, MN 56401 Phone: 218-829-2861 | |
James Freeman, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 2024 S 6th St, Brainerd, MN 56401 Phone: 218-825-7100 |